KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Equity Income (2016)

Charles River Laboratories International (CRL) has 5 years of Equity Income data on record, last reported at $442000.0 in Q3 2016.

  • For Q3 2016, Equity Income fell 86.36% year-over-year to $442000.0; the TTM value through Sep 2016 reached $8.7 million, up 58.05%, while the annual FY2015 figure was $3.8 million, 58.9% down from the prior year.
  • Equity Income reached $442000.0 in Q3 2016 per CRL's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $6.1 million in Q1 2014 and bottomed at -$907000.0 in Q2 2015.
  • Average Equity Income over 5 years is $1.4 million, with a median of $1.1 million recorded in 2013.
  • Peak YoY movement for Equity Income: surged 6882.22% in 2014, then plummeted 143.69% in 2015.
  • A 5-year view of Equity Income shows it stood at -$373000.0 in 2012, then surged by 386.33% to $1.1 million in 2013, then skyrocketed by 80.15% to $1.9 million in 2014, then crashed by 88.62% to $219000.0 in 2015, then surged by 101.83% to $442000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Equity Income were $442000.0 in Q3 2016, $5.0 million in Q2 2016, and $3.1 million in Q1 2016.